Leveraging murine models of the neurofibromatosis type 1 cancer predisposition syndrome to elucidate the cellular circuits that drive pediatric low-grade glioma formation and progression. | Neurooncol Adv;6(1): vdae054, 2024. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

Leveraging murine models of the neurofibromatosis type 1 cancer predisposition syndrome to elucidate the cellular circuits that drive pediatric low-grade glioma formation and progression.

Gutmann, David H.

Affiliation

Gutmann DH; Department of Neurology, Washington University School of Medicine, St. Louis, Missouri, USA.

Neurooncol Adv ; 6(1): vdae054, 2024.

Article in En | MEDLINE | ID: mdl-38855054

Key words

NF1; ecosystem; low-grade glioma; neurofibromatosis; optic glioma

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Neurooncol Adv Year: 2024 Document type: Article Affiliation country: Estados Unidos Country of publication: Reino Unido

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Neurooncol Adv Year: 2024 Document type: Article Affiliation country: Estados Unidos Country of publication: Reino Unido